key: cord-0863169-yaoepu7x authors: Albon, Dana; Bruschwein, Heather; Soper, Morgan; List, Rhonda; Jennings, Deirdre; Gettle, Lucy; Compton, Martina; Bailey, Molly; Starheim, Elissa; Murray, Rachel; Kalmanek, John; Somerville, Lindsay title: Impact of COVID-19 on social determinants of health for adults with cystic fibrosis date: 2021-08-21 journal: Ther Adv Respir Dis DOI: 10.1177/17534666211037459 sha: 680a72a45021a24be79b517dd370dc21a8f505f4 doc_id: 863169 cord_uid: yaoepu7x INTRODUCTION: Outcomes in cystic fibrosis are influenced by multiple factors, including social determinants of health. Low socioeconomic status has been shown to be associated with lung function decline, increased exacerbation rates, increased health care utilization, and decreased survival in cystic fibrosis. The COVID-19 pandemic disrupted the US economy, placing people with cystic fibrosis at risk for negative impacts due to changes in social determinants of health. METHODS: To characterize the impact of COVID-19-related changes in social determinants of health in the adult cystic fibrosis population, a social determinants of health questionnaire was designed and distributed to patients as part of a quality improvement project. RESULTS: Of 132 patients contacted, 76 (57.6%) responses were received. Of these responses, 22 (28.9%) answered yes to at least one question that indicated an undesired change in social determinants of health. Patients with stable employment prior to COVID-19 were more likely to endorse undesired change in all domains of the questionnaire, and the undesired changes were most likely to be related to employment, insurance security, and access to medications. Patients receiving disability were more likely to report hardship related to utilities and food security compared with patients previously employed or unemployed. Of patients endorsing risk of socioeconomic hardship, 21 (95.5%) were contacted by a social worker and provided resources. CONCLUSION: Utilizing a social determinants of health questionnaire to screen for social instability in the context of COVID-19 is feasible and beneficial for patients with cystic fibrosis. Identifying social issues early during the pandemic and implementing processes to provide resources may help patients with cystic fibrosis mitigate social hardship and maintain access to health care and medications. Cystic fibrosis (CF) is an autosomal recessive systemic disorder primarily characterized by respiratory disease. Mortality and morbidity in CF are influenced by multiple genetic and nongenetic factors. Over the past 10 years, CF survival has increased; however, among patients with similar genotypes, outcomes can differ greatly due to socioeconomic factors. 1, 2 Social determinants of health (SDH) are 'conditions in the places where people live, learn, work, and play that affect a wide range of health risks and outcomes'. 3 The Centers for Disease Control and Prevention (CDC) further delineates SDH into five key areas: health care access and quality, economic stability, education access and quality, social and community context, and neighborhood/environment. 3 SDH have been found to impact the outcomes of patients with CF, even from a young age. Differences in weight, lung function, and survival have been noticed in children with CF from different socioeconomic backgrounds despite similar prescriptions of CF medications. Lower socioeconomic status (SES) has been associated with increased pulmonary exacerbations, disease severity, increased antibiotic requirements, greater health care utilization, and decreased quality of life and survival in CF. 1, 2, [4] [5] [6] [7] [8] [9] Disparities in access to health care based on access to insurance have been attributed to differences in CF outcomes between the United States and Canada. A 41% lower risk of death in Canada compared with the United States has been shown, but when adjusted for private insurance, there was no difference in CF survival. 10 The gap in survival widened to 44% when compared with Medicaid/ Medicare insurance and to 77% when compared with no insurance or unknown insurance status in the CF population in the United States. 10 During the COVID-19 pandemic, large disruptions in the economy and changes in SES occurred that could negatively impact health outcomes of people with CF. Between March and April of 2020, the time during which this project occurred, 22 million people applied for unemployment in United States, independent of education and median household income. 11 As a result, we are facing socioeconomic hardship even in patients with high-level education and previously robust SES; this may lead to self-care disruptions, chronic disease instability, and increased health care utilization and hospitalizations in a health care system already weakened by the pandemic. Patients with known socioeconomic hardship, low income, and housing and food instability are even more vulnerable to economic turmoil. Consideration of SDH during COVID-19 cannot be overlooked, and there is a growing call for prioritization of policies, public initiatives, and research related to this area. 12, 13 Aim This project sought to investigate and describe the impact of the COVID-19 pandemic on SDH in our adult CF patient population. We sought to understand the new social environment and facilitate access to assistance resources to minimize disruptions in health insurance, health care and access to medications, and other domains. A COVID-19-specific SDH questionnaire was designed and distributed by an adult CF multidisciplinary team at an academic health center in the Southeastern United States as part of a quality improvement project. The questionnaire was distributed to adults with CF who had been seen in the CF clinic in 2019 and 2020 ( Figure 1 ). The questionnaire administration and follow-up occurred between March and April, 2020. Most Patients who had attended CF clinic appointments in 2019 and 2020 were sent the questionnaire between March and April 2020. All participants were at least 18 years old. The CF multidisciplinary team contacted 132 (94.3%) of 140 patients who had attended appointments in the adult CF clinic in 2019 and 2020 and received responses from 76 (57.6%) patients; eight patients could not be reached because they did not have an active MyChart or had a nonfunctional phone number in their EMR ( Figure 1 ). The demographic distribution of patients who answered the questionnaire was similar to that of the entire adult CF clinic population, and the sample group of respondents was considered representative of the target population, adults with CF seen in this CF clinic ( Table 2) . Out of 132 patients contacted by the team, 76 (57.6%) responses were received ( Table 3 ). The majority of responses (93.4%) were received via phone, email, or MyChart, and five patients were interviewed during clinic visits. The parent of one patient with cognitive impairment completed the questionnaire on behalf of the patient. Of 76 patients who responded to the questionnaire, 22 (28.9%) answered at least one question affirmatively. Multiple affirmative answers were endorsed by 10 patients (13.2%); eight of these patients reported that they lost their job, lost insurance, or were concerned about losing their insurance and reported either housing or food insecurity or both. The other two patients who answered affirmatively to more than one question were only concerned about future possible impacts. The domains most endorsed were employment and food security; over a quarter of respondents (26.3%) reported that they either lost their job or were concerned of losing their job and 17.1% reported concerns related to affording food at the time of administration of questionnaire or after. Fewer patients reported concerns regarding insurance coverage (7.9%), medication access (6.6%), utilities (6.6%), and transportation (2.6%). All patients unemployed prior to the COVID-19 pandemic had health insurance; five out of nine (55.6%) had private insurance and four out of nine (33.3%) had Medicaid/Medicare (Table 4 ). Most were married or in a stable relationship and had additional financial family support. Their social situation did not change significantly during the COVID-19 pandemic, with most change and hardship being related to partner/family social stability. All patients receiving disability prior to COVID-19 also had health insurance coverage (18.2% private insurance, 81.8% Medicaid/Medicare) and thus less likely to report insurance instability. Has your transportation been affected due to COVID-19? 2 (2.6) Utilities Are you concerned that your utilities (gas, water, electricity) will be shut off in the next few weeks? 5 (6.6) a. Are you able to afford enough food to feed yourself and your family? 6 (7.9) b. Are you concerned that in the next few weeks you will no longer be able to afford food? 7 (2.6) Are you concerned that you will not be able to afford or access your CF medications in time for your next refill? Any affirmative answer 22 (28.9) CF, cystic fibrosis; SDH, social determinants of health. a Bold italic font represents cumulative affirmative answers for each domain. Patients who were employed prior to COVID-19 were more likely to answer affirmatively to the SDH screening in all domains, as 37.5% responded affirmatively to at least one question versus 25.0% of unemployed patients and 21.1% of patients receiving disability. Affirmative answers endorsed by patients employed prior to COVID-19 were more likely to be related to loss of employment, concern for loss of employment, insurance security, and access to medications (25.0%, 12.5%, 10%, and 10.0%, respectively) ( Table 5 ). Patients receiving disability were more likely to report hardship related to ability to afford utilities (13.7%) and food security (15.8%) when compared with patients employed prior to COVID-19 (5.0% and 7.5%, respectively) or unemployed (11.1% and 11.1%, respectively) ( Table 5 ). One patient enrolled in school reported loss of employment and concern for employment. No retired patients reported social hardship in context of COVID-19. Patients insured by Medicaid/Medicare were more likely to report a change in housing, and financial hardship in relationship to utilities and food stability, while patients insured by private payors prior to COVID-19 were more likely to report concern related to losing employment and journals.sagepub.com/home/tar 7 health insurance (Table 5 ). Only one patient who was uninsured reported social hardship (CF-specific medication access). Patient employment status was affected by the COVID-19 pandemic similarly across education level, as patients with both some high school education (14.3%) and some college education (19.5%) reported employment insecurity and patients in both education levels lost employment (Table 5 ). Regarding age, employed patients had a mean age The CF team social worker attempted to contact all patients who answered affirmatively to any question to provide support and resources (Table 6) and was able to reach 21 of 22 patients (95.5%). The social worker contacted 4 patients by phone (18.2%), spoke in clinic with 5 patients (22.7%), and shared resources via MyChart with 12 patients (54.5%) who answered any question affirmatively. One patient (4.5%) could not be reached by phone or MyChart after multiple attempts. No patient previously on cystic fibrosis transmembrane conductance regulator (CFTR) modulators, a CF-specific medication, lost access to these medications. There are increasing calls for consideration and examination of SDH during COVID-19. Sharma and colleagues 14 surveyed the effect of COVID-19 on low-income households with children and found that over half reported concerns about financial stability, food availability, and food insecurity; almost half reported employment concerns; and approximately one-third endorsed housing and health care access concerns. Associations between race or ethnicity and low SES and increased occurrence of COVID-19 and related hospitalizations have been found, 15 as well as higher occurrence of COVID-19, increased mortality, and a higher prevalence of Table 6 . Social work response to undesired change in SDH. Response or resource provided by social worker • Housing stability was assessed for all patients • Discussed available resources/currents laws and policies that protect patients from eviction • Information on regional shelter availability was provided to homeless patients 2. Employment • Unemployment application and stimulus package forms were made available for patients • Letters for support for work from home were made available 3. Insurance • Provided assistance with Medicaid, COBRA, and alternative insurance plan application and federally supported insurance • Compass a information was made available to inquire for additional support • Transportation assistance discussed with patients who could become ensured through Medicaid • Compass a information was made available to inquire for additional support, as limited transportation assistance exists in the community • Letters for support offered for electricity maintenance • Compass a information was made available to inquire for additional support 6. Food security • Supplemental Nutrition Assistance Program (SNAP) resources were provided • Regional resources provided depending on patient residence 7. Medication access • Patient assistance forms for medications were offered to patients who could no longer afford CF-specific therapies CF, cystic fibrosis; COBRA, Consolidated Omnibus Budget Reconciliation Act; SDH, social determinants of health. a Compass is the Cystic Fibrosis Foundation's patient assistance service offered free of charge for persons with CF. Additional information can be found at https://www.cff.org/Assistance-Services/About-Compass/What-Is-Compass/. 8 journals.sagepub.com/home/tar chronic health conditions in economically vulnerable areas. 16, 17 While research on the impact of COVID-19 on SDH has increased, little is known regarding effects on specific patient populations, including chronic disease. A survey by Singh and colleagues 18 The socioeconomic stability of patients with chronic disorders like CF is threatened by the need for social distancing and economic changes in the era of COVID-19; however, social distancing is paramount in protecting the health of those with chronic disorders who are at higher risk of morbidity and mortality due to infections. In addition, patients with CF have increased risk of complications if they develop a pulmonary exacerbation related to respiratory viruses, including COVID-19. Some of the adults with CF followed up in our clinic were not provided the ability to work from home to observe social distancing and as a result, were either released from their duties or quit their jobs to avoid unnecessary exposure to COVID-19. A total of nine patients (11.8%) reported job loss at the time of the questionnaire and an additional 11 (14.5%) reported concern about losing their job in the near future. Patients with both high school and college levels of education reported similar concerns related to job security in the context of COVID-19. Workers across the United States have experienced furloughs and unemployment during COVID-19. As of May 2021, there were 9.3 million unemployed persons in the United States (in February 2020 prior to COVID-19, there were 5.7 million unemployed persons). 19 Over 25% of the patients who responded to the questionnaire endorsed loss of employment or concern for loss of employment. It is not surprising that we identified high unemployment rates in our patient population; however, unemployment for people with CF can quickly lead to uncontrolled respiratory disease, decline in lung function, and increased exacerbation rates when associated with loss of insurance benefits and access to health care and medications. This area is a priority for interventions to assist this population. Most of the patients with CF who reported changes in housing were able to maintain stable housing by moving in with family or friends. However, for the few patients who experienced homelessness, affordable housing resources were scarce and social distancing in shelters was difficult to achieve. Multiple interventions were implemented by local organizations and coalitions to support the people who experience homelessness in urban areas. However, for patients who reside in rural areas and depend on family for emotional and social support, moving to a nearby city for shelter is not feasible. This CF team's goal is to provide equitable care to all patients with CF and to identify early barriers to health care that can be overcome with assistance from the team and CF community. Through this questionnaire, we were able to identify social changes and rapidly intervene for mitigation of social hardship, providing resources to over 95% of the patients who endorsed risk of socioeconomic hardship. The CFF has also provided people with CF with multiple resources and programs that address social issues. However, some patients have not yet returned to clinic since the onset of COVID-19 and have not answered multiple contact attempts to schedule a clinic visit either through telemedicine or in person. There is concern that these patients are undergoing social hardship that prohibits them from reaching out for health care. In addition, these patients may not be aware of existing resources or feel comfortable asking for help. It is unclear how to reach these patients or how to identify if help is needed. This was a limitation of the study, and additional research in this area is greatly needed. A quality improvement process for delivery of an SDH screening questionnaire was designed and successfully implemented in our clinic, and we continue to offer the questionnaire during patient visits. This questionnaire has the potential to impact health care beyond this clinic, as it can be utilized by other CF centers, clinics who deliver care for patients with other chronic conditions, and in the primary care setting. This was a singlecenter quality improvement project, and future research should include multicenter and long-term data collection regarding impact of COVID-19 on SDH in patients with CF and other chronic disease populations. In addition, future research should include a focus on programs and public policies that may be beneficial in mitigating the effects of changes in SHD on vulnerable populations, including patients with chronic diseases such as CF; the use of control groups; and comparison of CF patients to the general population's experience during COVID-19 to better understand the impact on SDH specific to the CF population. Screening for social hardship in chronic disorders like CF is feasible and important in the context of COVID-19 socioeconomic changes. Understanding the disruptions in patients' SDH during the pandemic allows for early interventions and mitigation to minimize disruptions in health care and ensure continuity in health insurance, access to health care, housing, and food stability. Socioeconomic status and health outcomes: cystic fibrosis as a model The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States 2018 patient registry annual data report Median household income and mortality rate in cystic fibrosis Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis Relationship between socioeconomic status and disease severity in cystic fibrosis Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study Unemployment benefits: 22 million Americans have filed for unemployment benefits in the last four weeks COVID-19 and the impact of social determinants of health COVID-19 and the social determinants of health Social determinants of health-related needs during COVID-19 among low-income households with children Social determinants of COVID-19 incidence and outcomes: a rapid review Social inequality and the syndemic of chronic disease and COVID-19: county-level analysis in the USA Impact of social determinants of health on the emerging COVID-19 pandemic in the United States Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study The Employment Situation The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a Cystic Fibrosis Foundation grant (No. 000447CC319). Heather Bruschwein https://orcid.org/0000-0003-1180-5149 Supplemental material for this article is available online.